Introduction: Treatment of microbial infections has become complicated due to increased resistance of microbes to the current drugs. The current study investigates crude extracts and seven compounds from root and stem bark of Cordia africana Lam. for antimicrobial and cytotoxic activity. Methods: Extraction was done using 50% methanol in dichloromethane, followed by chromatographic separation of compounds, whose structures were established by interpretation of spectroscopic data. The in vitro susceptibility of selected microbes to the crude extracts and pure compounds was determined. Cytotoxicity of 1, 6 and 7 was determined against the drug sensitive, CCRF-CEM and resistant CEM/ADR-5000 cells, with doxorubicin used as the standard. Results: The root bark extract of C. africana yielded six known compounds: oleanolic acid (1), 3-β-lup-20(29)-en-3-ol (2) stigmast-5,22-dien-3β-ol (3), 2-(2Z) -(3-hydroxy-3,7-dimethylocta-2,6-dienyl)-1,4-benzenediol (4), 4-hydroxy-3-methoxy-benzaldehyde (5) and 7-hydroxy-4′-methoxyisoflavone (6). The stem bark extract resulted to 1 and 2 alongside, ubiquinone-8 (7) and 1-octacosanol (8). Compound 1 showed moderate activity against Enterococcus faecium (IC 50 of 14.44 µg/ mL), with vancomycin being inactive. Compounds 1, 6 and 7 showed cell viability >50% against CEM/ADR5000 and CCRF-CEM cells at 10 µM and therefore were considered inactive. Surprisingly, 1 was relatively more active compared to the standard, with cell viability of 57.93% against CEM/ ADR5000, versus 78.97% for doxorubicin. Conclusion: To the best of our knowledge, this is the first report of the eight compounds from C. africana. The cytotoxicity of 1, 6 and 7 are reported here for the first time. Traditional use of the plant extract in management of various infections may be attributed to presence of 1, which displayed moderate antimicrobial activity. Key words: Cordia africana, Ubiquinone-8, Oleanolic acid acid, 7-hydroxy-4′-methoxyisoflavone, VRE. 
INTRODUCTION
Vancomycin resistant Enterococci (VRE) infections are caused by E. feacalis and E. feacium, which account for 80-90% of clinical cases. 1 VRE infections mostly occur in intra-abdominal sites, in the urinary tract, bloodstream and at surgery sites, thus increasingly affect immunecompromised patients and those with prolonged hospitalization. 2, 3 Treatment of these infections involve combinations of antibiotics, but this is challenged by the fact that these microbes have developed resistance to all currently available antibiotics, including vancomycin which for thirty years had been used without notable resistance. 4, 5 Cordia africana Lam syn. C. abyssinica R.Br. (Boraginaceae) belongs to genus Cordia, which has about 250 plant species. The genus is widely used to treat many diseases, including microbial infections. 6 Different classes of compounds including hydroquinones, terpenoid quinones, phenolic compounds, terpenoids, flavonoids, lignans, porphyrins, phenyl propanoids and saponins have been reported from the genus Cordia. 6, 7 Some of these compounds and crude extracts have exhibited potential anticancer, antioxidant, antimicrobial and anti-inflammatory activities. 7 Commonly known as Sudan teak or East African Cordia, the evergreen small to medium sized tree that grows to a height of 4-15 m is found in tropical and sub-tropical climate areas including Central and South America, India, Asia and Africa. 8 Despite the ethno-medical use of C. africana to treat coughs, asthma, tuberculosis, wounds, toothache, tonsillitis and eye infections, 8 10 Further attempts to authenticate C. africana medicinal use led to chromatographic separation and purification, of the root bark and stem bark extracts, yielding eight pure compounds. Antimicrobial potential and cytotoxicity of the isolated compounds have also been reported in the current study.
MATERIALS AND METHODS

General Information
Thin layer chromatography (TLC) was performed on analytical TLC alumina plates pre-coated with silica gel 60 PF 254+366 (Merk, 0.25 mm thick) and spots visualized using UV lamp at wavelength of 254, 366 nm and exposure to iodine vapor. Column chromatography (CC) was run using silica gel 60 (Merk, 0.063-0.200 mm) and preparative thin layer chromatography on glass plates (0.5 mm thick): silica gel (Merk) 60 GF 254 on 20 × 20 cm 2 . Crystallization and Sephadex LH-20 on glass column were applied for purification of isolated compounds. 1 H and 13 C NMR (600, 500 MHz) were recorded on Brucker Avance DPX 300 spectrometer. Chemical shifts are given in d values relative to internal standard TMS whereas coupling constant (J) is given in hertz (Hz). Multiplicity of the signals is defined using the following abbreviations: s (singlet), d (doublet), t (triplet), dd (double doublet), q (quartet). Melting points were determined on Stuart scientific apparatus fitted with a thermometer, with temperature range of 0-250 0 C. Electron impact (EI) mass spectrometry was done on MAT SSQ 7000 single quadrupole instrument at 70 eV.
Plant Material
The root bark and stem bark of Cordia africana Lam. were collected from Muthetheni, Machakos county, Kenya (approximately 40 km from Nairobi city) and identified by a botanist Mr. Patrick Mutiso, from the School of Biological Studies (SBS), University of Nairobi, herbarium where a voucher specimen labelled, RWK 2017/01 is deposited.
Extraction and Isolation
The shade dried plant materials were separately ground into fine powder using RRH-1000A(K) multifunctional grinder and then exhaustively extracted by cold percolation in 1:1 methanol (MeOH)/dichloromethane (CH 2 Cl 2 ) followed by concentration in vacuo to produce 80 g and 110 g root bark and stem bark extracts, respectively. About 70 g of root-bark extract was loaded onto a column (70 g, SiO 2 gel) and elution was achieved with n-hexane (n-C 6 H 12 ), CH 2 Cl 2 :n-C 6 H 12 and MeOH/CH 2 Cl 2 solvent mixtures in increasing polarity. This yielded six (RWK 3A-3F) combined fractions, based on similarity on analytical TLC profiles. Compound 2 (30.8 mg) was obtained as white needle-shaped crystals (R f = 0.21, under 60% CH 2 Cl 2 / n-C 6 H 12 , m.p. = 214-216°C, Lit. = 213.8-215. 2 11 ), from the fraction RWK 3B (1.0g) of the main column eluted with 80% CH 2 Cl 2 /n-C 6 H 12 , followed by crystallization in CH 2 Cl 2 /n-C 6 H 12 . Fraction RWK 3C (1.02 g) afforded 3 and 4 upon repeated CC using EtOAc/n-C 6 H 12 mixture in increasing polarities. Compound 3 (30 mg) was isolated as white needle shaped crystals, (R f = 0.39 under 10% EtOAc/n-C 6 H 12, m.p. = 172-174°C, Lit. = 174-176°C. 12 The sub-fraction obtained from RWK 3C was subjected to CC, followed by preparative TLC using 10% EtOAc/n-C 6 H 12 affording yellow solid of 4 (11.5 mg, R f = 0.36, under 15% EtOAc/n-C 6 H 12 ). CC of the combined fractions RWK 3D and 3E (2.93 g) using CH 2 Cl 2 /n-C 6 H 12 in increasing polarity gave yellow powder of 5 (8.6 mg, R f = 0.34 under 80% CH 2 Cl 2 / n-C 6 H 12 ) and white powder (5 mg) of 1 (R f = 0.31 under 1% MeOH/CH 2 Cl 2, m.p. = ˃ 250 °C, Lit. = 336°C). 13 Compound 6 (4.5 mg, R f = 0.5 under 4% MeOH/CH 2 Cl 2, m.p. = ˃ 250 °C, Lit. = 255-256°C) 14 was obtained as yellow powder from fraction RWK 3F (0.9 g) through CC using MeOH/ CH 2 Cl 2 solvent mixture, followed by crystallization and separation by size exclusion using Sephadex-LH 20. Similar procedures were performed on the stem bark extract (100 g) to yield 1 (60 mg) and 2 (56 mg) initially isolated from root bark extract. In addition, compound 7 (25 mg, R f = 0.28 under 50% CH 2 Cl 2 /n-C 6 H 12 ) was obtained as orange resin from a fraction of the main column eluted with 35% CH 2 Cl 2 /n-C 6 H 12 . Further chromatographic separation with CH 2 Cl 2 n-C 6 H 12 mixtures of increasing polarity yielded 8 (30 mg, R f = 0.28 under 60% CH 2 Cl 2 /n-C 6 H 12 , m.p. = 78-80°C). Structures of the pure compounds were elucidated by use of HRMS, 1D and 2D 1 H-NMR, 13 C-NMR spectral data and with close comparison with published data for related compounds. Crude extracts were tested against all strains at 200 µg/mL in duplicate to determine % inhibition. Pure compounds were dissolved to make a stock solution of 2 mg/mL. They were tested at concentrations of 20, 4 and 0.8 µg/mL and IC 50 's determined. The IC 50 values were calculated using XLFit fit curve fitting software.
Antimicrobial Activities
Cytotoxicity Assay
The resazurin assay 16 was applied to determine in vitro cell viability of the pure compounds against doxorubicin sensitive CCRF-CEM and resistant CEM/ADR-5000 lymphoblasts obtained from Germany collection for microorganisms and cell culture. The standard anticancer drug doxorubicin (98% pure) from Sigma-Aldrich, Schnelldorf, Germany) was used as positive control. Pure compounds were dissolved to make a test concentration of 10 µM. Samples that showed cell viability below 50 % had their IC 50 values obtained from dose response curves.
RESULTS AND DISCUSSION
Chromatographic separation of the root bark extract of C. africana yielded three triterpenoids; oleanolic acid acid (1), 13 3-β-lup-20(29)-en-3-ol (2) 11 and stigmast-5,22-dien-3β-ol (3) 12 a hydroquinone derivative, 2-(2Z) -(3-hydroxy-3,7-dimethylocta-2,6-dienyl)-1,4-benzenediol (4), 17 benzaldehyde derivative, 4-hydroxy-3-methoxy-benzaldehyde (5) 18 and isoflavone, 7-hydroxy-4′-methoxyisoflavone (6) 14 ( Figure 1) . Similarly, the stem bark extract led to re-isolation of 1 and 2 together with terpenoid benzoquinone ubiquinone-8 (7) 19 and an alcohol, 1-octacosanol (8). 20 The structures of these compounds were elucidated based on interpretation of H-NMR spectrum of 6 displayed six aromatic (δ H 8.14, 8.04, 6.92, 6.84, 7.47×2, 6.98×2 ppm ), one methoxy (δ H 3.78 ppm) and one chelated hydroxyl proton (δ H 10.8 ppm). One of the aromatic protons (δ H 8.14 ppm), suggested its β-position attachment with respect to a carbonyl group (δ c 178.1 ppm) as well as direct attachment to electron withdrawing oxygen atom at position C-1. This suggested an isoflavove skeleton and close study of COSY, HMQC and HMBC correlations, HRMS fragmentation pattern, together with comparison with published compounds led to identification of the compound as 7 -hydroxy-4′-methoxyisoflavone (6), previously reported from the clover, Trifolium repens, 14 Bolusanthus specious 21 and Eysenhardtia polystachya. 22 Compound 7, known to be synthesized by Escherichia coli, was previously characterized from a predatory gram-negative bacterium, Bdellovibrio bacteriovorus 109J. 19 However, its occurrence in plants as well as detailed structural elucidation details are unknown and therefore the motivation to provide the spectroscopic data for this compound. The molecular formula of compound 7 was determined as C 49 H 74 O 4 , from interpretation of ESI-mass spectrum (Figure 2 24 Study of long range correlations revealed two methoxy, methyl and isoprenyl substituents assigned to C-2, C-3, C-5 and C-6, respectively. This assignment matched that of a meroterpenoid benzoquinone, previously isolated from roots of C. globosa 24 but differed on substituents at C-5 and C-6 position. The presence of eight olefinic protons at δ H 4.95-5.13 ppm, thirty methylene protons and nine methyl protons confirmed a C-40 isoprenoid group, which was attached at position C-6 of the benzoquinone. Close comparison of the observed values with literature spectral and physical data led to the identification of the compound as ubiquinone-8 (UQ-8), previously characterized from a predatory gram-negative bacterium, Bdellovibrio bacteriovorus 109J 19 through semi-prep HPLC analysis. This compound belongs to a group of compounds known as ubiquinones (UQs), identified by presence of benzoquinone ring attached to poly-isoprenoid side chain, with the length varying with source organism. The compounds UQ-8, with eight isoprene units is known to be synthesized in Escherichia coli, where it serves as a cellular radical scavenger as well as an electron carrier in respiratory chain. 25 It is reported that plant ubiquinones usually consist of nine to ten isoprene units, which is contrary to the present study which reports UQ-8 with eight units from the stem bark of Cordia africana. The genus Cordia has previously yielded reduced forms of benzoquinones as well as meroterpenoid benzoquinones. Alencar and coworkers (2005) reported a meroterpenoid benzoquinone from the roots of C. globosa. 24 The compound had a C-4 and C-5 methoxy substituted benzoquinone skeleton but the C-40 side chain observed in UQ-8 was missing, instead, it had two isoprene units, in form of fused rings. To the best of our knowledge this is the first report of 7 in the plant kingdom. The crude extracts and all compounds except 5 were tested for antibacterial and antifungal activities against C. albicans ATCC 90028, A. fumigatus ATCC 204305, C. neoformans ATCC 90113, K. pneumonia ATCC 2146, methicillin resistant Staphylococcus aureus MRSA 33591, E. coli ATCC 35218, P. aeruginosa ATCC 27853 and vancomycin resistant Enterococcus (VRE) E. faecium ATCC 700221. The crude extracts were inactive towards the tested microorganisms as their IC 50 values were >200 mg/mL which could be attributed to the inactivity of most constituent compounds. However, 1 showed moderate activity against VRE (E. faecium ATCC 700221) with IC 50 value of 14.44 µg/mL (Table 1) , versus vancomycin which was inactive at a concentration range of 4-100 µg/mL. The rest of the compounds did not show inhibition towards the growth of the microbes at concentration range of 0.8-20 µg/mL. Oleanolic acid (1), is found in a wide range of medicinal and edible plants. 26 Comprehensive studies have revealed its therapeutic potential as an antitumor, 27 antidiabetic, 28 antihypertensive, 29 antioxidant, 30 anti-inflammatory, 31 anti- 33 However, in the current study when the test concentration was lowered to 20 µg/mL, compound 1 was found selective towards VRE, showing activity towards only E. feacalis ATCC 700221 with an IC 50 value of 14.44 µg/mL and inactive towards S. aureus and P. aeruginosa. Compounds 1, 6 and 7 were isolated in sufficient quantities and were also tested for their cytotoxicity against drug sensitive CCRF-CEM and resistant CEM/ADR 5000 human leukemic lymphoblast. These compounds exhibited cell viability ˃ 50% at the tested concentration of 10 µM and therefore were considered inactive. Nevertheless, oleanolic acid (1) was relatively more active than doxorubicin against CEM/ADR 5000 as it displayed cell inhibition of 42.07% versus 21.03%, respectively.
CONCLUSION
The current study has revealed eight compounds 1-8 for the first time in this plant. Compound 7 is reported for the first time in plant kingdom, earlier known to be produced by gram negative bacteria only. Oleanolic acid (1) showed moderate activity (IC 50 =14.44 µg/mL) towards VRE (Enterococcus faecium 700221), compared to the standard drug, vancomycin, which was inactive at the same concentration. Compounds 1, 6 and 7 were inactive (cell viability ˃ 50% at 10 µM) towards CCRF-CEM and CEM/ADR 5000 human leukemic lymphoblast. The traditional use of the plant extracts in the management of various infections would be attributed to the presence of oleanolic acid which displayed moderate antimicrobial activity.
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